venBio Partners — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

Impel Neuropharmaimpelneuropharma.com in 𝕏Nov 2016SEC filingmedium confidence

Impel Pharmaceuticals develops therapies for diseases with high unmet medical needs by pairing established drugs with its proprietary upper-nasal drug delivery technology.

BiotechHealthtechMedical DevicesSeattle, US

John D. Hoekman(Executive Officer, Director)in

BoardMichael Hite(Director)Stewart Parker(Director)

Board seatAaron Royston· per SEC Form D · $37.3M raise · filed Dec 2016

Co-investors5AM Ventures B Capital Group venBio Global Strategic Westlake Village BioPartners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.